Menu Close

VAERS Data since Launch of COVID Experimental mRNA Gene Therapy

VAERS

VAERS was initiated in 1990 as a follow-up of the US National Childhood Vaccine Injury Act. The Vaccine Adverse Event Reporting System is run by the CDC and FDA. Reporting on adverse reactions or possible adverse reactions is mandatory for hospitals, physicians, and others professionally licensed to order and/or administer vaccines and mRNA gene therapies which have been given Emergency Use Authorization by the FDA — which originally described them as “unapproved product[s]” with potential to achieve vaccine status upon proof of safety and efficacy.

A description of VAERS from the official HHS website.

Syria News provides this short report as a public service announcement, as ongoing transatlantic news on the current SARS-CoV pandemic are focused almost exclusively on enhancement of fear among an already terrified population, and on personal stories from the grief-stricken who have buried loved ones.

From late December 2020 through 22 January 2021, there have been three hundred twenty-nine (329) VAERS reported deaths — from 0 to 12 days — post receipt of either Pfizer or Moderna’s mRNA products. The majority of these cases come from mandatory reporting, though some involve voluntary reporting of persons finding dead or dying relatives in their homes.

The majority of these deaths were among the very old, most of which were injected in their nursing homes, ‘residents” with extensive medical histories (SMQ‘ is the acronym for Standardized MedDRA Queries, more readily grasped as Past Medical History), though some were quite young. Two suicides were listed; this may be noteworthy as several “write-ups” included complaints by patients of inexplicable agitation. Among included signs and symptoms pre-mortality were abrupt neurological changes and nausea and vomiting (the gastric problems are better understood knowing that the breathing and vomiting centers are located in the primitive brain stem; their proximity meets with the concept of evolution.).

Some of the VAERS reports were extensive, though none explained how consent was received among those unable to consent because of dementia.

The reasonable standard of care included in licensed practitioner acts would suggest that persons with histories of anaphylaxis, Neuroleptic Malignant Syndrome, Anticholinergic Syndrome, Guillain-Barre Syndrome, and even those with ejection fractions barely compatible with life, be excluded from these trials. Yet there are many among the VAERS dead with these known histories.

In 2003, the NIH published a review, Antibody-dependent enhancement of virus infection and disease, in which the author noted that “[t]he presence of specific antibodies can be beneficial to the virus.” On 28 October 2020, the NIH issued a publication titled, Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease. This one was COVID – 19 explicit: Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern: that vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralizing antibodies), be they composed of protein, viral vector, DNA or RNA and irrespective of delivery method, may worsen COVID-19 disease via antibody-dependent enhancement (ADE). This risk is sufficiently obscured in clinical trial protocols and consent forms for ongoing COVID-19 vaccine trials that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

Despite the NIH study, and the urgent call just a few months ago, on ADE, many of those on the deceased list had COVID positive in their histories.

One VAERS came as a batch of 7 residents of 8 who had passed before receiving their second doses.

More than one “Write up” included a description of a non-responsive DNR resident being given morphine and other drugs that can suppress respiratory activity, despite no mention of the patient being in respiratory distress (though most think of this short-acting narcotic being a pain medication, it, more importantly, decreases the workload of the heart, when it’s under duress). Such “write-ups” leave open the inference that some may being euthanized — illegal in the US, and also a breach of the Nuremberg Statutes, to which the US is signatory.

This Syria News writer has decided to use the database of the Medalerts website, as it is more ‘user-friendly,’ than that of HHS, which requires a download. Please note that all of these cases ID each VAERS concern, and the ID numbers can be used for further verification.

Miri Wood

Postscript: I chose a featured image of exuberant kids having fun — Piaget noted “Play is the work of children” — as a visual antidote to much of the MSM diminishing and defaming children and teens as virulent pathogenic vectors of COVID, while averting their collective gaze from those responsible for dumping COVID positives into nursing homes, causing the deaths of thousands of at-risk, geriatrics.

To help us continue, please visit the Donate page to donate or learn how to help us at no cost.
Follow us on Telegram: http://t.me/syupdates link will open the Telegram app.

Latest News:

6 Comments

  1. Miri Wood

    In 2012, NIH published this report, “Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus” which studied mice. It might account for some of the VAERS deaths that included pleural effusions and other pulmonary edema. It might also suggest that those with idiopathic pulmonary fibrosis should be exempted from these injections. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335060/

Comments:

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

GDPR rules by the EU: Syria News will use the information you provide on this form to be in touch with you and to provide updates and marketing.
donate